Form 4 for HCA HCA Healthcare
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-11 · accession 0001209191-22-057098 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-15 | 2022-11-11 | HCA | Hall Charles J | Group Pres | M - OptEx | $145.24 | +12.0K | 211.9K | +6% | +$1.74M |
| D | 2022-11-15 | 2022-11-11 | HCA | Hall Charles J | Group Pres | F - Tax | $224.08 | -9,440 | 202.4K | -4% | -$2.12M |
| D | 2022-11-15 | 2022-11-11 | HCA | Hall Charles J | Group Pres | M - OptEx | $0.00 | -12.0K | 23.9K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | M | A | 12,000 | $145.24 | 211,883 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-11 | F | D | 9,440 | $224.08 | 202,443 | D | — | — | |
| 3 | Derivative | Stock Appreciation Right | 2022-11-11 | M | D | 12,000 | $0.00 | 23,880 | D | $145.24 · — to 2030-01-29 | 12,000 Common Stock | (F1) The stock appreciation rights vest in four equal annual installments beginning on January 29, 2021. |